Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
The Journal of Infectious Diseases|April 1, 1997
Immunoprophylaxis of group B respiratory syncytial virus infection in cotton ratsL A Faverio, F M Piazza, S A Johnson, et al.The Journal of Infectious Diseases|July 1, 1991
Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infectionsP M Muelenaer, F W Henderson, V G Hemming, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunityR A Olmsted, N Elango, G A Prince, et al.Mucosal Immunology|April 21, 2010
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependentK A Shirey, L M Pletneva, A C Puche, et al.Pediatric Pulmonology|June 1, 1995
A cotton rat model of effectors of immunity to respiratory syncytial virus other than serum antibodyF M Piazza, H J Schmidt, S A Johnson, et al.Journal of Clinical Microbiology|August 1, 1986
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccineB R Murphy, G A Prince, E E Walsh, et al.Vaccine|December 1, 1988
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virusR A Olmsted, R M Buller, P L Collins, et al.Journal of Virology|October 24, 2000
Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton ratsG A Prince, C Capiau, M Deschamps, et al.Human Gene Therapy|October 1, 1995
Characterization of an adenovirus gene transfer vector containing an E4 deletionD Armentano, C C Sookdeo, K M Hehir, et al.The Journal of Infectious Diseases|June 3, 1999
A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9S Johnson, S D Griego, D S Pfarr, et al.Pageof 8